|
Perspectives
Citations 51-60 of 68 total displayed.
|
Past content
(since Apr 1999):
|
Von Willebrand disease type 1: a diagnosis in search of a disease
- J. Evan Sadler
Blood 2003; 101: 2089-2093.
[Abstract]
[Full text]
[PDF]
RANK ligand and osteoprotegerin in myeloma bone disease
- Orhan Sezer, Ulrike Heider, Ivana Zavrski, Christian Alexander Kühne, and Lorenz Christian Hofbauer
Blood 2003; 101: 2094-2098.
[Abstract]
[Full text]
[PDF]
Noninvasive measurement of iron: report of an NIDDK workshop
- Gary M. Brittenham and David G. Badman
Blood 2003; 101: 15-19.
[Abstract]
[Full text]
[PDF]
The chiaroscuro stem cell: a unified stem cell theory
- Peter J. Quesenberry, Gerald A. Colvin, and Jean-Francois Lambert
Blood 2002; 100: 4266-4271.
[Abstract]
[Full text]
[PDF]
Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation
- James J. Biagi and John F. Seymour
Blood 2002; 99: 4265-4275.
[Abstract]
[Full text]
[PDF]
Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia
- Jens Pedersen-Bjergaard, Mette K. Andersen, Debes H. Christiansen, and Claus Nerlov
Blood 2002; 99: 1909-1912.
[Abstract]
[Full text]
[PDF]
Acute promyelocytic leukemia: evolving therapeutic strategies
- Martin S. Tallman, Chadi Nabhan, James H. Feusner, and Jacob M. Rowe
Blood 2002; 99: 759-767.
[Abstract]
[Full text]
[PDF]
Discrepancies between genotype and phenotype in hematology: an important frontier
- Ernest Beutler
Blood 2001; 98: 2597-2602.
[Abstract]
[Full text]
[PDF]
Chronic myeloid leukemia: current treatment options
- John M. Goldman and Brian J. Druker
Blood 2001; 98: 2039-2042.
[Abstract]
[Full text]
[PDF]
Genetic hypercoagulability: screening should be an informed choice
- David Green
Blood 2001; 98: 20.
[Full text]
[PDF]
|
|
